FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q44772343> ?p ?o ?g. }

• Q44772343 description "2008 nî lūn-bûn" @default.
• Q44772343 description "2008年の論文" @default.
• Q44772343 description "2008年学术文章" @default.
• Q44772343 description "2008年学术文章" @default.
• Q44772343 description "2008年学术文章" @default.
• Q44772343 description "2008年学术文章" @default.
• Q44772343 description "2008年学术文章" @default.
• Q44772343 description "2008年学术文章" @default.
• Q44772343 description "2008年學術文章" @default.
• Q44772343 description "2008年學術文章" @default.
• Q44772343 description "2008年學術文章" @default.
• Q44772343 description "2008年學術文章" @default.
• Q44772343 description "2008年學術文章" @default.
• Q44772343 description "2008년 논문" @default.
• Q44772343 description "article científic" @default.
• Q44772343 description "article scientific" @default.
• Q44772343 description "article scientifique" @default.
• Q44772343 description "articol științific" @default.
• Q44772343 description "articolo scientifico" @default.
• Q44772343 description "artigo científico" @default.
• Q44772343 description "artigo científico" @default.
• Q44772343 description "artigo científico" @default.
• Q44772343 description "artikel ilmiah" @default.
• Q44772343 description "artikull shkencor" @default.
• Q44772343 description "artikulong pang-agham" @default.
• Q44772343 description "artykuł naukowy" @default.
• Q44772343 description "artículo científico publicado en 2008" @default.
• Q44772343 description "artículu científicu" @default.
• Q44772343 description "bilimsel makale" @default.
• Q44772343 description "bài báo khoa học" @default.
• Q44772343 description "naučni članak" @default.
• Q44772343 description "scienca artikolo" @default.
• Q44772343 description "scientific article published in February 2008" @default.
• Q44772343 description "scientific article published in February 2008" @default.
• Q44772343 description "scientific article published in February 2008" @default.
• Q44772343 description "teaduslik artikkel" @default.
• Q44772343 description "tieteellinen artikkeli" @default.
• Q44772343 description "tudományos cikk" @default.
• Q44772343 description "vedecký článok" @default.
• Q44772343 description "vetenskaplig artikel" @default.
• Q44772343 description "videnskabelig artikel" @default.
• Q44772343 description "vitenskapelig artikkel" @default.
• Q44772343 description "vitskapeleg artikkel" @default.
• Q44772343 description "vědecký článek" @default.
• Q44772343 description "wetenschappelijk artikel" @default.
• Q44772343 description "wissenschaftlicher Artikel" @default.
• Q44772343 description "επιστημονικό άρθρο" @default.
• Q44772343 description "мақолаи илмӣ" @default.
• Q44772343 description "наукова стаття, опублікована в лютому 2008" @default.
• Q44772343 description "научна статия" @default.
• Q44772343 description "научная статья" @default.
• Q44772343 description "научни чланак" @default.
• Q44772343 description "научни чланак" @default.
• Q44772343 description "מאמר מדעי" @default.
• Q44772343 description "مقالة علمية نشرت في فبراير 2008" @default.
• Q44772343 description "ফেব্রুয়ারি ২০০৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q44772343 description "บทความทางวิทยาศาสตร์" @default.
• Q44772343 description "სამეცნიერო სტატია" @default.
• Q44772343 name "CA125 velocity at relapse is a highly significant predictor of survival post relapse: results of a 5-year follow-up survey to a randomized placebo-controlled study of maintenance oregovomab immunotherapy in advanced ovarian cancer" @default.
• Q44772343 name "CA125 velocity at relapse is a highly significant predictor of survival post relapse: results of a 5-year follow-up survey to a randomized placebo-controlled study of maintenance oregovomab immunotherapy in advanced ovarian cancer" @default.
• Q44772343 type Item @default.
• Q44772343 label "CA125 velocity at relapse is a highly significant predictor of survival post relapse: results of a 5-year follow-up survey to a randomized placebo-controlled study of maintenance oregovomab immunotherapy in advanced ovarian cancer" @default.
• Q44772343 label "CA125 velocity at relapse is a highly significant predictor of survival post relapse: results of a 5-year follow-up survey to a randomized placebo-controlled study of maintenance oregovomab immunotherapy in advanced ovarian cancer" @default.
• Q44772343 prefLabel "CA125 velocity at relapse is a highly significant predictor of survival post relapse: results of a 5-year follow-up survey to a randomized placebo-controlled study of maintenance oregovomab immunotherapy in advanced ovarian cancer" @default.
• Q44772343 prefLabel "CA125 velocity at relapse is a highly significant predictor of survival post relapse: results of a 5-year follow-up survey to a randomized placebo-controlled study of maintenance oregovomab immunotherapy in advanced ovarian cancer" @default.
• Q44772343 P1433 Q44772343-1151DAA7-A73C-4F56-9910-D343AC8A7754 @default.
• Q44772343 P1476 Q44772343-B27392DF-7945-42E7-B4C8-FDD30A30A70C @default.
• Q44772343 P2093 Q44772343-67271B49-4371-4407-8223-9B81B01F8B9A @default.
• Q44772343 P2093 Q44772343-9D55AF46-DBCB-415F-B276-5B641CA6590A @default.
• Q44772343 P2093 Q44772343-DDEC1CA7-F8E6-4538-A5A0-46879F0BF71D @default.
• Q44772343 P304 Q44772343-959D3690-6A6D-4D2F-BC52-C8686CF2A8B0 @default.
• Q44772343 P31 Q44772343-966E05D7-A399-4017-9300-5A9CF2B182BB @default.
• Q44772343 P356 Q44772343-ECDA28AC-8CBC-4B92-B2AE-227D594A6C9D @default.
• Q44772343 P433 Q44772343-BF343E7D-8979-46D5-9C07-A4E36938BD00 @default.
• Q44772343 P478 Q44772343-502740AE-140E-4E56-ABD4-4D5B241ED746 @default.
• Q44772343 P577 Q44772343-4FBF8B3A-60ED-49FC-9C5A-D675A0D18E2E @default.
• Q44772343 P698 Q44772343-1F7BA329-E49A-4FC3-A949-E38F9630DA2C @default.
• Q44772343 P921 Q44772343-36301391-527F-4A0C-9603-771FEDE6147C @default.
• Q44772343 P921 Q44772343-63B7599C-6EED-49A0-BF23-7ED533F9958D @default.
• Q44772343 P921 Q44772343-6F7D655D-8E4B-4432-8F2D-F7232E0819A2 @default.
• Q44772343 P356 CJI.0B013E31816060CE @default.
• Q44772343 P698 18481390 @default.
• Q44772343 P1433 Q15763946 @default.
• Q44772343 P1476 "CA125 velocity at relapse is a highly significant predictor of survival post relapse: results of a 5-year follow-up survey to a randomized placebo-controlled study of maintenance oregovomab immunotherapy in advanced ovarian cancer" @default.
• Q44772343 P2093 "Christopher F Nicodemus" @default.
• Q44772343 P2093 "Jonathan S Berek" @default.
• Q44772343 P2093 "Peyton T Taylor" @default.
• Q44772343 P304 "207-214" @default.
• Q44772343 P31 Q13442814 @default.
• Q44772343 P356 "10.1097/CJI.0B013E31816060CE" @default.
• Q44772343 P433 "2" @default.
• Q44772343 P478 "31" @default.
• Q44772343 P577 "2008-02-01T00:00:00Z" @default.
• Q44772343 P698 "18481390" @default.
• Q44772343 P921 Q1427096 @default.
• Q44772343 P921 Q172341 @default.
• Q44772343 P921 Q269829 @default.